Phase 1 Clinical Trial Launched Examines Safety, Efficacy of Stem Cell Treatment for Parkinson Disease

Phase 1 Clinical Trial Launched Examines Safety, Efficacy of Stem Cell Treatment for Parkinson Disease

Source: Psychiatric Times

A new trial is testing a first-of-its-kind stem cell therapy for Parkinson disease, using a patient’s own reprogrammed cells to restore lost dopamine function.

Solarseven/AdobeStock
A first-of-its-kind phase 1 open-label clinical trial at Mass General Brigham is evaluating an innovative treatment for Parkinson disease by using a patient’s own reprogrammed stem cells to replace dopamine neurons damaged by th… [4122 chars]

Read more